A Multicenter, Open-Label, Randomized, Two Arm Study to Investigate the Efficacy and Safety of a Therapy Avoiding Intraoperative Steroids in Combination With Basiliximab, Ciclosporin/Ciclosporin Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients.
Phase of Trial: Phase III
Latest Information Update: 16 Apr 2016
At a glance
- Drugs Basiliximab; Ciclosporin; Corticosteroids
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 21 Sep 2011 Actual end date (March 2009) added as reported by ClinicalTrials.gov.
- 21 Sep 2011 Trial phase is III as reported by ClinicalTrials.gov.
- 09 Feb 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.